US Stock MarketDetailed Quotes
VRCA Verrica Pharmaceuticals
- 1.530
- +0.130+9.29%
Close Nov 1 16:00 ET
- 1.500
- -0.030-1.96%
Post 18:07 ET
65.28MMarket Cap-809P/E (TTM)
1.555High1.410Low485.09KVolume1.430Open1.400Pre Close722.60KTurnover2.81%Turnover RatioLossP/E (Static)42.67MShares11.41052wk High-4.90P/B26.45MFloat Cap1.04052wk Low--Dividend TTM17.29MShs Float23.290Historical High--Div YieldTTM10.36%Amplitude1.040Historical Low1.489Avg Price1Lot Size
About Verrica Pharmaceuticals Company
Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.
Company Profile
SymbolVRCA
Company NameVerrica Pharmaceuticals
Listing DateJun 15, 2018
Issue Price15.00
Founded2013
CEOMr. Ted White
MarketNASDAQ
Employees100
Fiscal Year Ends12-31
Address44 West Gay Street,Suite 400
CityWest Chester
ProvincePennsylvania
CountryUnited States of America
Zip Code19380
Phone1-434-453-3300
Websitehttp://www.verrica.com
Company Executives
- Name
- Position
- Salary
- Ted White
- Chief Executive Officer, President and Director
- 3.50M
- Christopher G. Hayes
- Chief Legal Officer
- 2.56M
- Gary Goldenberg
- Chief Medical Officer
- --
- Paul B. Manning
- Chairman of the Board
- --
- Sean Stalfort
- Director
- --
- Dr. Diem Nguyen, M.B.A.,PhD
- Independent Director
- 99.19K
- Mark A. Prygocki, Sr
- Independent Director
- 119.19K
- Dr. Lawrence Eichenfield, M.D.
- Independent Director
- 119.19K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data